St. Jude Medical's statement on settlement agreement with U.S. DOJ

NewsGuard 100/100 Score

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today issued the following statement in connection with a settlement agreement reached with the U.S. Department of Justice (DOJ) regarding a previously disclosed July 2007 investigation in Ohio related to certain rebates:

We are pleased to have reached a settlement agreement with the DOJ that fully resolves our previously disclosed investigation in Ohio. Importantly, in connection with this settlement, St. Jude Medical does not admit liability or wrongdoing. The allegations centered on small, isolated product rebates that the company paid more than five years ago. The company entered into a settlement agreement in order to avoid the potential costs and risks associated with litigation.

The agreement brings full and final closure to the matter in Ohio.

As part of this settlement, the company will make a payment of $3,725,000 to the DOJ. St. Jude Medical affirms that the resolution of this matter has no material impact on the company's financial position or operations.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.